Back
CytoMed Therapeutics Stock Predictions
Sponsored
GDTC
Sponsored
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
50
GDTC
CytoMed Therapeutics
Last Price:
1.95
Seasonality Move:
-37.85%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.CytoMed Therapeutics Stock Forecast
-
Is CytoMed Therapeutics Stock Undervalued?
The current CytoMed Therapeutics [GDTC] share price is $2.17. The Score for GDTC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal. - GDTC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will CytoMed Therapeutics Stock Go Up Next Year?
Data Unavailable
CytoMed Therapeutics Stock Rating
Data Unavailable
CytoMed Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Singapore
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
w2.cytomed.sg
52-Week Data
52-Week High:
5.50
52-Week Low:
1.20
Prediction Charts
Market Cap:
25.09M
Price in USD:
2.17
Volume:
10.78K
Beta:
-0.09
Technical Analysis
SMA50:
2.01
SMA100:
1.92
SMA200:
2.05
52-Wk Change:
-45.78%
Stock Predictions
-
Is CytoMed Therapeutics stock public?
Yes, CytoMed Therapeutics is a publicly traded company. -
What is the CytoMed Therapeutics stock quote today?
The CytoMed Therapeutics stock price is 2.17 USD today. -
How to buy CytoMed Therapeutics stock online?
You can buy CytoMed Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-29 | 2.47 | 2.34 | 2.50 | 2.13 |
Oct-30 | 2.21 | 2.23 | 2.30 | 2.15 |
Oct-31 | 2.45 | 2.41 | 2.45 | 2.27 |
Nov-1 | 2.45 | 2.31 | 2.45 | 2.28 |
Nov-4 | 2.26 | 2.48 | 2.58 | 2.25 |
Nov-5 | 2.61 | 2.62 | 2.83 | 2.41 |
Nov-6 | 2.44 | 2.44 | 2.49 | 2.36 |
Nov-7 | 2.29 | 2.54 | 2.59 | 2.24 |
Nov-8 | 2.15 | 2.31 | 2.55 | 2.14 |
Nov-11 | 2.11 | 2.39 | 2.69 | 2.11 |
Nov-12 | 2.31 | 2.27 | 2.31 | 2.18 |
Nov-13 | 2.40 | 2.22 | 2.60 | 2.15 |
Nov-14 | 2.37 | 2.12 | 2.40 | 2.12 |
Nov-15 | 2.20 | 2.17 | 2.52 | 1.83 |
CytoMed Therapeutics Earnings
Data Unavailable
CytoMed Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.02 per share.
* CytoMed Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.